Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/172848
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBellomo, Claudia-
dc.contributor.authorCaja Puigsubirà, Laia-
dc.contributor.authorFabregat Romero, Isabel-
dc.contributor.authorMikulits, Wolfgang-
dc.contributor.authorKardassis, Dimitris-
dc.contributor.authorHeldin, Carl-Henrik-
dc.contributor.authorMoustakas, Aristidis-
dc.date.accessioned2020-12-17T16:02:58Z-
dc.date.available2020-12-17T16:02:58Z-
dc.date.issued2017-12-11-
dc.identifier.issn1350-9047-
dc.identifier.urihttp://hdl.handle.net/2445/172848-
dc.description.abstractUnderstanding the complexity of changes in differentiation and cell survival in hepatocellular carcinoma (HCC) is essential for the design of new diagnostic tools and therapeutic modalities. In this context, we have analyzed the crosstalk between transforming growth factor β (TGFβ) and liver X receptor α (LXRα) pathways. TGFβ is known to promote cytostatic and pro-apoptotic responses in HCC, and to facilitate mesenchymal differentiation. We here demonstrate that stimulation of the nuclear LXRα receptor system by physiological and clinically useful agonists controls the HCC response to TGFβ. Specifically, LXRα activation antagonizes the mesenchymal, reactive oxygen species and pro-apoptotic responses to TGFβ and the mesenchymal transcription factor Snail mediates this crosstalk. In contrast, LXRα activation and TGFβ cooperate in enforcing cytostasis in HCC, which preserves their epithelial features. LXRα influences Snail expression transcriptionally, acting on the Snail promoter. These findings propose that clinically used LXR agonists may find further application to the treatment of aggressive, mesenchymal HCCs, whose progression is chronically dependent on autocrine or paracrine TGFβ.-
dc.format.extent19 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41418-017-0021-3-
dc.relation.ispartofCell Death and Differentiation, 2017-
dc.relation.urihttps://doi.org/10.1038/s41418-017-0021-3-
dc.rightscc by-nc-nd (c) Bellomo et al., 2017-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/-
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)-
dc.subject.classificationCàncer de fetge-
dc.subject.classificationTerapèutica-
dc.subject.otherLiver cancer-
dc.subject.otherTherapeutics-
dc.titleSnail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec676666-
dc.date.updated2020-12-17T16:02:58Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29230000-
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
676666.pdf5.37 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons